AB144504
BQ 788 sodium salt, ETB receptor antagonist
Be the first to review this product! Submit a review
|
(1 Publication)
MW 663.8 Da, Purity >98%. Highly potent, selective ETB receptor antagonist (IC50 values are 1.2 and 1300 nM for ET-1 binding to ETB and ETA, respectively). Inhibits ET-1 induced vasoconstriction, bronchoconstriction and cell proliferation. Shows antitumor effects.
1 Images
- Chemical Structure
Lab
Chemical Structure - BQ 788 sodium salt, ETB receptor antagonist (AB144504)
2D chemical structure image of ab144504, BQ 788 sodium salt, ETB receptor antagonist
Properties and storage information
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Disease models & mechanisms 14: PubMed34664634
2021
Early manifestations and differential gene expression associated with photoreceptor degeneration in Prom1-deficient retina.
Applications
Unspecified application
Species
Unspecified reactive species
Yuka Kobayashi,Shizuka Watanabe,Agnes Lee Chen Ong,Manabu Shirai,Chiemi Yamashiro,Tadahiko Ogata,Fumiaki Higashijima,Takuya Yoshimoto,Takahide Hayano,Yoshiyuki Asai,Noriaki Sasai,Kazuhiro Kimura
Product promise
We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com